Company Overview
More
China Pioneer Pharmaceutical Holdings Co., Ltd. is an investment holding company mainly engaged in comprehensive marketing, promotion and channel management services of pharmaceutical products and medical devices. The company operates through two business divisions. Ophthalmic Pharmaceutical products Division sells ophthalmic pharmaceutical products through the provision of channel management services and joint promotion services. The product segment, which provides integrated marketing, promotion and channel management services, mainly sells all pharmaceutical products and medical devices except ophthalmic pharmaceutical products. The company is also engaged in the manufacturing of chemical and pharmaceutical products through its subsidiaries.
CEO： Xinzhou Li
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
01345 PIONEER PHARM
2.460-0.020-0.81%
YOY
Do not show
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
-34.27%
294.95M
-35.09%
217.14M
14.08%
448.73M
4.11%
334.52M
Accounts receivable
-16.71%
306.26M
-11.44%
308.8M
12.32%
367.69M
5.69%
348.68M
Related party payments receivable
-99.83%
75K
-76.78%
14.1M
391.53%
43.07M
4.69%
60.74M
Advance deposits and other receivables
--
--
--
--
-58.67%
3.32M
-85.27%
4.34M
Withholding and tax receivable
94.95%
3.21M
--
--
-76.85%
1.64M
1113.99%
4.16M
Cash and equivalents
95.51%
224.85M
-1.9%
162.55M
-57.45%
115.01M
65.2%
165.7M
Secured deposit
-18.58%
6.57M
-96.76%
340K
-35.36%
8.07M
14.26%
10.48M
Financial assets at fair value-current assets
26.96%
177.23M
455.96%
130M
-29.69%
139.6M
-88.46%
23.38M
Special items of current assets
--
--
--
--
--
--
--
816K
Total current assets
-10.11%
1.01B
-12.58%
832.92M
-8.67%
1.13B
-9.36%
952.81M
Non-current assets
Property, plant and equipment
13.96%
83.71M
51.94%
84.96M
54.77%
73.45M
22.65%
55.92M
Advance payment
2.64%
16.59M
--
--
--
16.16M
--
--
Long-term receivables
--
--
--
--
--
--
-77.58%
857K
Associated company interest
147.05%
89.47M
71.68%
103.25M
47.6%
36.21M
-0.46%
60.14M
Intangible assets
-2.36%
45.92M
571.92%
46.02M
292.58%
47.03M
-49.1%
6.85M
Deferred tax assets
-38.75%
11.96M
8.62%
12.74M
150.69%
19.52M
12.16%
11.73M
Special items of non-current assets
-37.85%
67.69M
-45.65%
84.79M
-51.24%
108.92M
-28.78%
155.99M
Total non-current assets
4.66%
315.34M
13.82%
331.76M
-4.8%
301.3M
-17.37%
291.48M
Total assets
-7%
1.33B
-6.4%
1.16B
-7.88%
1.43B
-11.37%
1.24B
Liabilities
Current liabilities
Accounts payable
-30.98%
297.05M
-33.73%
102.78M
39.87%
430.36M
-16.62%
155.1M
Tax payable
-18.46%
24.61M
-49.6%
14.59M
0.74%
30.18M
120.4%
28.94M
Dividend payable
--
--
--
--
--
--
--
38.71M
Amounts payable to associated parties-current liabilities
--
2.03M
--
--
--
--
--
1.7M
Bank loans and overdrafts
-8.15%
13.87M
100.71%
89.07M
-69.09%
15.1M
-29.11%
44.38M
Financial lease liabilities-current liabilities
1514.29%
113K
--
--
-94.07%
7K
-95.43%
121K
Special items of current liabilities
19.35%
10.52M
-27.46%
8.92M
-18.48%
8.82M
46.59%
12.3M
Total current liabilities
-28.13%
348.2M
-23.43%
215.36M
21.38%
484.46M
2.39%
281.25M
Net current assets
3.47%
664.95M
-8.04%
617.57M
-23.03%
642.68M
-13.51%
671.57M
Total assets less current liabilities
3.85%
980.28M
-1.43%
949.33M
-18.02%
943.98M
-14.72%
963.05M
Non-current liabilities
Financial lease liabilities-non-current liabilities
--
71K
--
--
--
--
--
9K
Deferred tax liability
99.37%
25.63M
60.66%
12.85M
73.69%
12.85M
--
8M
Deferred income-non-current liabilities
124.61%
43.6M
--
19.41M
--
19.41M
--
--
Total non-current liabilities
114.78%
69.3M
302.85%
32.26M
331.97%
32.26M
340.78%
8.01M
Total liabilities
-19.2%
417.49M
-14.39%
247.62M
27.09%
516.73M
4.62%
289.25M
Total assets less total liabilities
-0.08%
910.99M
-3.98%
917.06M
-20.3%
911.72M
-15.29%
955.04M
Total equity and non-current liabilities
3.85%
980.28M
-1.43%
949.33M
-18.02%
943.98M
-14.72%
963.05M
Equity
Share capital
0%
77.57M
0%
77.57M
0%
77.57M
-0.25%
77.57M
Reserve
-0.18%
830.4M
-4.57%
835.41M
-21.82%
831.87M
-16.66%
875.45M
Legal reserve
-0.18%
830.4M
-4.57%
835.41M
-21.82%
831.87M
-16.66%
875.45M
Shareholders' Equity
-0.16%
907.97M
-4.2%
912.98M
-20.33%
909.43M
-15.53%
953.02M
Non-controlling interest
32.22%
3.02M
101.68%
4.08M
-6.48%
2.28M
365.4%
2.03M
Total equity
-0.08%
910.99M
-3.98%
917.06M
-20.3%
911.72M
-15.29%
955.04M
Total equity and total liabilities
-7%
1.33B
-6.4%
1.16B
-7.88%
1.43B
-11.37%
1.24B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang Accountants--
Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%